Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 07:53 am Sale | 2024-12-31 | 13G | Verve Therapeutics, Inc. VERV | STATE STREET CORP STT | 3,235,747 3.800% | -1,017,470 (-23.92%) | Filing History |
| 2025-01-31 4:00 pm Sale | 2024-12-31 | 13G | Verve Therapeutics, Inc. VERV | Millennium Management LLC | 3,919,131 4.600% | -1,446,090 (-26.95%) | Filing History |
| 2025-01-10 9:24 pm Sale | 2024-09-30 | 13G | Verve Therapeutics, Inc. VERV | ARK Investment Management LLC | 0 0.000% | -7,025,116 (Position Closed) | Filing History |
| 2024-11-18 5:23 pm Purchase | 2024-11-11 | 13G | Verve Therapeutics, Inc. VERV | BIOTECHNOLOGY VALUE FUND L P | 6,904,050 8.200% | 6,904,050 (New Position) | Filing History |
| 2024-11-12 5:52 pm Unchanged | 2024-09-30 | 13G | Verve Therapeutics, Inc. VERV | The Vanguard Group | 4,005,161 4.730% | 0 (Unchanged) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Verve Therapeutics, Inc. VERV | BlackRock Inc. BLK | 7,276,347 8.600% | 0 (Unchanged) | Filing History |
| 2024-11-04 1:52 pm Sale | 2024-09-30 | 13G | Verve Therapeutics, Inc. VERV | The Vanguard Group | 4,005,161 4.730% | -1,466,769 (-26.81%) | Filing History |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | Verve Therapeutics, Inc. VERV | BlackRock Inc. BLK | 7,276,347 8.600% | 2,840,866 (+64.05%) | Filing History |
| 2024-10-16 1:06 pm Purchase | 2024-09-30 | 13G | Verve Therapeutics, Inc. VERV | STATE STREET CORP STT | 4,253,217 5.000% | 386,453 (+9.99%) | Filing History |
| 2024-09-09 4:36 pm Purchase | 2024-08-30 | 13G | Verve Therapeutics, Inc. VERV | Millennium Management LLC | 5,365,221 6.300% | 1,064,216 (+24.74%) | Filing History |
| 2024-06-27 4:42 pm Purchase | 2024-06-21 | 13G | Verve Therapeutics, Inc. VERV | Millennium Management LLC | 4,301,005 5.100% | 4,301,005 (New Position) | Filing History |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | Verve Therapeutics, Inc. VERV | The Vanguard Group | 5,471,930 6.810% | 1,659,906 (+43.54%) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Verve Therapeutics, Inc. VERV | BlackRock Inc. BLK | 4,435,481 5.600% | 4,435,481 (New Position) | Filing History |
| 2024-01-29 4:00 pm Purchase | 2023-12-31 | 13G | Verve Therapeutics, Inc. VERV | ARK Investment Management LLC | 7,025,116 8.740% | 2,659,286 (+60.91%) | Filing History |
| 2024-01-23 10:13 am Sale | 2023-12-31 | 13G | Verve Therapeutics, Inc. VERV | STATE STREET CORP STT | 3,866,764 4.810% | -604,285 (-13.52%) | Filing History |
| 2024-01-16 11:45 am Sale | 2023-12-31 | 13G | Verve Therapeutics, Inc. VERV | SINGER JAMES R | 3,000,000 3.700% | -2,000,000 (-40.00%) | Filing History |
| 2023-12-11 4:16 pm Purchase | 2023-12-01 | 13G | Verve Therapeutics, Inc. VERV | GV 2017, L.P. | 12,349,086 15.400% | 1,800,000 (+17.06%) | Filing History |
| 2023-12-11 09:09 am Sale | 2023-12-08 | 13G | Verve Therapeutics, Inc. VERV | FMR LLC | 3,803,214 4.842% | -3,102,208 (-44.92%) | Filing History |
| 2023-02-14 10:40 am Purchase | 2022-12-31 | 13G | Verve Therapeutics, Inc. VERV | SINGER JAMES R | 5,000,000 8.100% | 2,535,000 (+102.84%) | Filing History |
| 2023-02-13 9:27 pm Sale | 2022-12-31 | 13G | Verve Therapeutics, Inc. VERV | Casdin Capital, LLC | 2,290,571 3.700% | -847,596 (-27.01%) | Filing History |